Skip to main content
Earnings Labs
Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ·Healthcare·Biotechnology

$477.86

+1.53%

Mkt Cap $121.09B

Analyst Ratings

Buy

21

Hold

4

Sell

1

Price Target (93 analysts)

$553.93

Range $436.00$616.00

Implied Upside

+15.9%

Consensus $553.93 vs current $477.86